Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raute Sunder-Plassmann

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Advances in Clinical Chemistry|January 26, 2007
Cytochrome P450: another player in the myocardial infarction game?Raute Sunder-Plassmann
Clinical Chemistry and Laboratory Medicine|November 11, 2010
Pharmacogenetics guided anticoagulationRaute Sunder-Plassmann, Christine Mannhalter
Cancers|July 14, 2023
Identification of Genetic Risk Factors for Keratinocyte Cancer in Immunosuppressed Solid Organ Transplant Recipients: A Case-Control StudyRaute Sunder-Plassmann, Alexandra Geusau, Georg Endler, et al.
European Heart Journal. Cardiovascular Imaging|July 23, 2019
First case of late onset cardiac phenotype Fabry disease due to an AluYb8 insertion in exon 7 of the GLA geneConstantin Gatterer, Dietrich Beitzke, Raute Sunder-Plassmann, et al.
Clinical Chemistry and Laboratory Medicine|April 22, 2005
Simultaneous analysis of MDR1 C3435T, G2677T/A, and C1236T genotypes by multiplexed mutagenically separated PCRRaute Sunder-Plassmann, Sandra Rieger, Georg Endler, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 30, 2006
The association of PC-1 (ENPP1) K121Q polymorphism with metabolic syndrome in patients with coronary heart diseaseIvan Tasic, Maja Milojkovic, Raute Sunder-Plassmann, et al.
Wiener Klinische Wochenschrift|January 18, 2012
Inhibitor development in two patients with mild haemophilia A - spontaneous disappearance and no recurrence of the inhibitor after re-challengeSylvia Reitter-Pfoertner, Birgit Horvath, Klaus Lechner, et al.
Thrombosis Research|March 29, 2017
Plasminogen activator inhibitor-1 4G/5G genotype and residual venous occlusion following acute unprovoked deep vein thrombosis of the lower limb: A prospective cohort studyGeorgiana-Aura Giurgea, Sophie Brunner-Ziegler, Bernd Jilma, et al.
Clinical Chemistry|November 26, 2004
CYP2C9*2 and CYP2C9*3 alleles confer a lower risk for myocardial infarctionMarion Funk, Georg Endler, Renate Freitag, et al.
Clinical Chemistry|August 27, 2005
Influence of cytochrome P450 2C9*2 and 2C9*3 variants on the risk of ischemic stroke: a cross-sectional case-control studyMarion Funk, Renate Freitag, Georg Endler, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Advances in Clinical Chemistry|January 26, 2007
Cytochrome P450: another player in the myocardial infarction game?Raute Sunder-Plassmann
Clinical Chemistry and Laboratory Medicine|November 11, 2010
Pharmacogenetics guided anticoagulationRaute Sunder-Plassmann, Christine Mannhalter
Cancers|July 14, 2023
Identification of Genetic Risk Factors for Keratinocyte Cancer in Immunosuppressed Solid Organ Transplant Recipients: A Case-Control StudyRaute Sunder-Plassmann, Alexandra Geusau, Georg Endler, et al.
European Heart Journal. Cardiovascular Imaging|July 23, 2019
First case of late onset cardiac phenotype Fabry disease due to an AluYb8 insertion in exon 7 of the GLA geneConstantin Gatterer, Dietrich Beitzke, Raute Sunder-Plassmann, et al.
Clinical Chemistry and Laboratory Medicine|April 22, 2005
Simultaneous analysis of MDR1 C3435T, G2677T/A, and C1236T genotypes by multiplexed mutagenically separated PCRRaute Sunder-Plassmann, Sandra Rieger, Georg Endler, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 30, 2006
The association of PC-1 (ENPP1) K121Q polymorphism with metabolic syndrome in patients with coronary heart diseaseIvan Tasic, Maja Milojkovic, Raute Sunder-Plassmann, et al.
Wiener Klinische Wochenschrift|January 18, 2012
Inhibitor development in two patients with mild haemophilia A - spontaneous disappearance and no recurrence of the inhibitor after re-challengeSylvia Reitter-Pfoertner, Birgit Horvath, Klaus Lechner, et al.
Thrombosis Research|March 29, 2017
Plasminogen activator inhibitor-1 4G/5G genotype and residual venous occlusion following acute unprovoked deep vein thrombosis of the lower limb: A prospective cohort studyGeorgiana-Aura Giurgea, Sophie Brunner-Ziegler, Bernd Jilma, et al.
Clinical Chemistry|November 26, 2004
CYP2C9*2 and CYP2C9*3 alleles confer a lower risk for myocardial infarctionMarion Funk, Georg Endler, Renate Freitag, et al.
Clinical Chemistry|August 27, 2005
Influence of cytochrome P450 2C9*2 and 2C9*3 variants on the risk of ischemic stroke: a cross-sectional case-control studyMarion Funk, Renate Freitag, Georg Endler, et al.
Pageof 6